| Members |
targetComponentId |
| schankriformt syndrom |
Cutaneous coccidioidomycosis |
| kaotisk miljö |
Chaotic environment (finding) |
| förkläde avböjt |
Provision of chaperone declined |
| Chaperone refused |
Provision of chaperone declined |
| Chaperone refused |
Provision of chaperone declined |
| egenskap som rör psykologisk perception |
Perception observable |
| Chediak-Higashi syndrome |
Chédiak-Higashi syndrome |
| kindlambå |
Flap (substance) |
| icke kärlsäkrad kindlambå |
Random pattern flap |
| allergi mot kelatkomplexbildare och antidoter |
Allergy to drug |
| Chemical destruction of lesion of organ NOC |
Chemosurgery |
| Chemical destruction of lesion of organ NOC NOS |
Chemosurgery |
| Chemical destruction of lesion of organ NOC OS |
Chemosurgery |
| Chemical destruction of organ NOC |
Chemosurgery |
| Chemical destruction of organ NOS |
Chemosurgery |
| Chemical element AND/OR compound |
Chemical categorized by structure (substance) |
| kemisk matförgiftning |
Food poisoning |
| kemiskt medel eller yttre faktor |
Substance |
| körsbär, livsmedel |
Cherry (substance) |
| bröstkorgslambå |
Flap (substance) |
| icke kärlsäkrad bröstkorgslambå |
Random pattern flap |
| Chewing symptom NOS |
Chewing finding |
| Chewing symptom NOS |
Chewing finding |
| symtom som rör tuggande |
Chewing finding |
| Chewing symptoms |
Chewing finding |
| protein i kycklingavföring |
Chicken droppings (substance) |
| Chickenpox with other specified complications |
Chickenpox with complication |
| Chikungunya hemorrhagic fever |
Chikungunya fever |
| Chilblain lupus erythematosus |
Sarcoidosis, lupus pernio type |
| screening för utvecklingshandikapp hos barn |
Screening for child developmental disorder (procedure) |
| Child developmental handicap screening |
Screening for child developmental disorder (procedure) |
| barn till patienten |
Child |
| anfall under barndomen |
Seizure |
| Chilognatha |
Class Diplopoda (organism) |
| kinarestaurangsyndromet |
Monosodium glutamate symptom complex |
| DNA från Chlamydia pneumoniae |
Chlamydophila pneumoniae DNA |
| kloralhydrat 250 mg/5 ml, sirap |
Chloral hydrate 50 mg/mL oral solution |
| kloralhydrat 10 g, suppositorium |
Chloral hydrate 650 mg rectal suppository |
| kloralhydrat 5 g, suppositorium |
Chloral hydrate 325 mg rectal suppository |
| kloralsedativ |
Chloral derivative (substance) |
| kloramin T-specifikt extrakt |
Product containing tosylchloramide sodium (medicinal product) |
| kloramfenikolantibiotika |
Chloramphenicol (substance) |
| kloramfenikol 0,25 %, ögondroppar |
Chloramphenicol (as chloramphenicol sodium succinate) 2.5 mg/mL eye solution |
| Chlorhexidine |
Product containing chlorhexidine (medicinal product) |
| klorhexidindiglukonat 0,05 % + ametokain 0,015 %, oral sprej |
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug) |
| klorhexidinglukonat 0,02 % i 70 % IMS, sprej |
Chlorhexidine gluconate 200 microgram/mL cutaneous spray |
| Chlorhexidine gluconate 0.02% in 70% IMS spray refill |
Chlorhexidine gluconate 200 microgram/mL cutaneous spray |
| klorhexidinglukonat 0,5 % i 70 % IMS, lösning |
Chlorhexidine gluconate 50 mg/mL cutaneous solution |
| klorhexidinglukonat 0,5 % i 70 % IMS, sprej |
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
| Chlorhexidine gluconate 0.5% in 70% IMS spray refill |
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
| klorhexidinglukonat 2 % / isopropanol 70 %, svamp för lokalt bruk |
Product containing only chlorhexidine and isopropyl alcohol (medicinal product) |
| klorhexidinglukonat 3,15 % / isopropanol 70 %, kompress för lokalt bruk |
Product containing only chlorhexidine and isopropyl alcohol (medicinal product) |
| klorhexidinglukonat 1 % + etylalkohol 61 %, lösning |
Product containing only chlorhexidine and ethanol (medicinal product) |
| klorhexidinglukonat 0,2 % + lidokainhydroklorid 0,05 %, munhålesprej |
Product containing only chlorhexidine and lidocaine (medicinal product) |
| klorhexidinglukonat 0,2 % + lidokainhydroklorid 0,05 %, svalgsprej |
Product containing only chlorhexidine and lidocaine (medicinal product) |
| Chlorhexidine gluconate+lidocaine hydrochloride 0.2%/0.05% throat spray |
Product containing only chlorhexidine and lidocaine (medicinal product) |
| Chlorhexidine gluconate+lignocaine hydrochloride 0.2%/0.05% throat spray |
Product containing only chlorhexidine and lidocaine (medicinal product) |
| klorhexidinglukonat 0,5 % / natriumnitrit 0,1 % i 70 % IMS, lösning |
Product containing precisely chlorhexidine gluconate 5 milligram/1 milliliter and sodium nitrite 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
| Chlorhexidine hydrochloride+neomycin sulfate |
Product containing chlorhexidine and neomycin (medicinal product) |
| biverkning av desinfektionsmedel med klorerad fenol |
Chlorinated phenol adverse reaction |
| allergi mot desinfektionsmedel innehållande klorerad fenol |
Allergy to chlorinated phenol (finding) |
| förgiftning orsakad av klorobensoesyra |
Poisoning by 4-chlorobenzoic acid |
| kloroformsubstans som missbrukas, icke läkemedel |
Chloroform |
| Chlorophenothane |
Clofenotane |
| kloroprokainhydroklorid 1 %, injektionsvätska, lösning, ampull |
Product containing only chloroprocaine (medicinal product) |
| kloroprokainhydroklorid 2 %, injektionsvätska, lösning, ampull |
Product containing only chloroprocaine (medicinal product) |
| kloroprokainhydroklorid 3 %, injektionsvätska, lösning, ampull |
Product containing only chloroprocaine (medicinal product) |
| Chloroxylenol |
Chloroxylenol (substance) |
| klorfeniramin 2 mg + ibuprofen 200 mg + pseudoefedrin 30 mg, kapsel |
Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) |
| klorfenamin 2 mg + ibuprofen 200 mg + pseudoefedrin 30 mg, tablett |
Product containing precisely chlorphenamine maleate 2 milligram and ibuprofen 200 milligram and pseudoephedrine hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) |
| Chlorpheniramine maleate |
Product containing chlorphenamine (medicinal product) |
| klorfeniraminmaleat + metskopolaminnitrat + pseudoefedrinhydroklorid 8 mg/2,5 mg/120 mg, tablett med modifierad frisätttning |
Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form) |
| klorfenaminmaleat 8 mg + metskopolaminnitrat 2,5 mg + pseudoefedrinhydroklorid 120 mg, depåtablett |
Product containing only chlorphenamine and methscopolamine and pseudoephedrine in oral dose form (medicinal product form) |
| Chlorpheniramine maleate + pseudoephedrine hydrochloride |
Product containing chlorphenamine and pseudoephedrine (medicinal product) |
| klorfeniraminmaleat + fenylefrinhydroklorid + fenyltoloxamincitrat 4 mg/20 mg/50 mg, kapsel med modifierad frisättning |
Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form |
| klorfenaminmaleat 4 mg + fenylefrinhydroklorid 20 mg + fenyltoloxamincitrat 50 mg, depåkapsel |
Chlorphenamine and phenylephrine and phenyltoloxamine only product in oral dose form |
| klorpromazinhydroklorid 10 mg/5 ml, sirap |
Chlorpromazine hydrochloride 2 mg/mL oral solution |
| klorpromazinhydroklorid 150 mg, kapsel med modifierad frisättning |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
| klorpromazinhydroklorid 150 mg, depåkapsel |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
| klorpromazinhydroklorid 30 mg, kapsel med modifierad frisättning |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
| klorpromazinhydroklorid 30 mg, depåkapsel |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
| klorpromazinhydroklorid 50 mg/5 ml, sirap |
Product containing precisely chlorpromazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
| klorpromazinhydroklorid 75 mg, kapsel med modifierad frisättning |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
| klorpromazinhydroklorid 75 mg, depåkapsel |
Product containing only chlorpromazine in oral dose form (medicinal product form) |
| Chlorprothixene overdose |
Chlorprothixene overdose (disorder) |
| klortetracyklinhydroklorid 3 %, salva |
Product containing precisely chlortetracycline 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
| kolesterolanalyt |
Cholesterol |
| avböjt deltagande i program med kolesterolsänkande kost |
Cholesterol reduction programme declined |
| kolestyramin + sackaros |
Product containing colestyramine (medicinal product) |
| kolestyramin 4 g, pulver |
Colestyramine 4 g powder for oral suspension sachet |
| Cholestyramine 4g suspension |
Colestyramine 4 g powder for oral suspension sachet |
| Cholestyramine 4g/unit powder |
Colestyramine 4 g powder for oral suspension sachet |
| Cholestyramine 4g/unt powder |
Colestyramine 4 g powder for oral suspension sachet |
| kolestyramin + aspartam |
Product containing colestyramine (medicinal product) |
| kolestyramin + aspartam, dospåse 4 g, pulver |
Colestyramine 4 g powder for oral suspension sachet |
| Choline salicylate 870mg/5ml liquid |
Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug) |
| kolinsalicylat 20 % + glycerol 12,6 %, örondroppar |
Product containing precisely choline 200 milligram/1 milliliter and glycerol 126 milligram/1 milliliter conventional release ear solution (clinical drug) |
| kolinteofyllinatallergi |
Allergy to theophylline (finding) |
| Chondrocalcinosis due to dicalcium phosphate crystals, NOS |
Chondrocalcinosis due to dicalcium phosphate crystals |
| Chondrocalcinosis due to dicalcium phosphate crystals, of other specified site |
Chondrocalcinosis due to dicalcium phosphate crystals |
| Chondrocalcinosis due to dicalcium phosphate crystals, of unspecified site |
Chondrocalcinosis due to dicalcium phosphate crystals |
FHIR